DRA COMPANY LIMITED entered into a share purchase agreement for a private placement of 100,000 common shares at a price of CNY 1,500 per share for gross proceeds of CNY 150,000,000 on January 22, 2018. The transaction will involve participation from new investor Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882). The transaction will take place in 3 periods. Post the closing of the transaction, the total share capital of the company will increase from 100,000 to 200,000 shares and the investor will hold 50% stake in the company. The transaction has been approved by the investor at the 21st meeting of its 1st directorate and is not subject to approval from its shareholders.